Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 3CNS 3Plasma cell 2Gastrointestinal 2Breast 2Thoracic 1NET 1Genitourinary 1Endocrine 1

Conditions

Prostatic Neoplasms 1Neuroendocrine Tumors 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Cancer Related Cognitive Difficulties 1Breast Neoplasms 1

Interventions

Paclitaxel 162Fulvestrant 156Trastuzumab 155pembrolizumab 145Letrozole 136Carboplatin 118Capecitabine 105pertuzumab 104Specimen Handling 102Cyclophosphamide 102Anastrozole 90palbociclib 86abemaciclib 82Magnetic Resonance Spectroscopy 81exemestane 76Docetaxel 76Tamoxifen 75ribociclib 74trastuzumab deruxtecan 70Radiotherapy 62Biopsy 59Surveys and Questionnaires 56Gemcitabine 53130-nm albumin-bound paclitaxel 53sacituzumab govitecan 51olaparib 51Blood Specimen Collection 50Standard of Care 49Taxes 48Doxorubicin 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neuropsychological Tests × Breast × 1 year × Clear all
NCT03137095 2026-04-24

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

University of Rochester

Recruiting
150 enrolled
Breast

Cancer Related Cognitive Difficulties

NCT04373564 2026-01-22

ODYSSEY

Guerbet

Phase 4 Recruiting
2,076 enrolled
BreastEndocrineGastrointestinalGenitourinaryNET

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡